查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1828111

2025年全球药物涂层球囊市场报告

Drug-Coated Balloons Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，药物涂层球囊市场快速扩张，从2024年的10.8亿美元成长到2025年的12.4亿美元，复合年增长率为14.6%。预测期内的增长归因于心血管疾病负担的增加、对微创手术的需求、周边动脉疾病（垫片）的流行、血管再阻塞介入性心臟病学的进步。

预计未来几年药物涂层球囊市场规模将快速成长，到2029年将达到22亿美元，复合年增长率为15.5%。预测期内的成长可归因于人口老化加剧、适应症和用途的拓展、对门诊和门诊护理的日益重视、与药物输送创新的融合以及全球健康计划。预测期内的主要趋势包括新製剂的监管核准、对副作用最小化的重视、生物可吸收涂层的出现、新兴国家的市场扩张以及以患者为中心的理念。

药物涂层球囊 (DCB) 是一种用于治疗血管狭窄或阻塞的医疗设备，特别适用于介入性心臟病学和介入放射学。 DCB 的设计目的是在血管成形术的同时，将药物直接输送到血管病变部位。

药物涂层球囊包括周边动脉疾病、冠状动脉疾病等疾病客製化的产品。周边动脉疾病DCB是一种用于治疗周边动脉疾病（PAD）的特殊医疗设备，其特征是心臟外和下肢血管狭窄或阻塞。 DCB使用多种类型的药物，例如紫杉醇和Sirolimus，最终用户包括医院、心导管室和门诊手术中心。

2025年春季，美国关税飙升及其引发的贸易摩擦对医疗设备产业产生了重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价，製造商面临利润压力。监管挑战使情况更加复杂，因为由于关税而更换供应商通常需要重新认证医疗设备，导致市场准入延迟。为此，企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分，该系列提供药物涂层球囊市场统计数据，包括全球市场规模、区域份额、竞争对手的市场份额、详细的药物涂层球囊细分市场、市场趋势和商机，以及您在药物涂层球囊行业取得成功所需的数据。本药物涂层球囊市场研究报告对该行业的现状和未来趋势进行了详细分析，为您提供所需的一切观点。

未来五年15.5%的预测成长率，较我们先前对该市场的预测略有下降0.1%。这一下降主要源自于美国与其他国家之间关税的影响。这可能会透过对来自印度和墨西哥等主要地区的抗增殖药物和球囊表面改质技术征收关税直接影响美国，从而导致血管内治疗方案减少，动脉疾病治疗成本上升。由于互惠关税以及不断升级的贸易摩擦和限制对全球经济和贸易的负面影响，这种影响也将更加广泛地显现。

冠状动脉疾病 (CAD) 盛行率的不断上升预计将推动药物涂层球囊市场的未来成长。 CAD 是一种以供应心肌血液的冠状动脉变窄或阻塞为特征的疾病，常导致心臟病发作。药物涂层球囊是用于治疗冠状动脉疾病的医疗设备。它们在手术过程中将药物释放到动脉中，以防止再血管再阻塞（血管成形术后动脉血管再阻塞）。例如，根据 2022 年 8 月发表在《美国心臟病学会杂誌》上的一项研究，预计 2025 年至 2060 年间美国普通人群的所有四种心血管风险因素都将增加。预计糖尿病增幅最大，为 39.3%，其次是血脂异常症（27.6%）、高血压（25.1%）及肥胖（18.3%）。此外，心臟衰竭（33.4%）和缺血性心臟疾病（30.7%）的发病率预计将增加最大，心肌梗塞（16.9%）和中风（33.8%）的发生率也将增加最大。因此，冠状动脉疾病盛行率的上升预计将推动药物涂层球囊市场的发展。

预计门诊手术中心数量的增加将推动药物涂层球囊市场的成长。门诊手术中心 (ASC) 是专门执行无需住院过夜手术的医疗机构。药物涂层球囊在 ASC 中发挥重要作用，它与标准球囊相比，手术时间更短，可以提高患者吞吐量并降低营运成本。例如，VMG Health 在 2023 年 9 月报告称，获得医疗保险 (Medicare) 认证的门诊手术中心总数将从 2021 年的 1,752 家增加 2.9% 至 2022 年的 1,804 家。因此，门诊手术中心的普及率不断提高正在推动药物涂层球囊市场的扩张。

产品创新已成为药物涂层球囊市场的关键趋势。该领域的主要企业正专注于开发新技术和创新解决方案，以提升其市场地位。例如，美国医疗技术公司碧迪公司 (BD) 于2022年8月启动了其周边Sirolimus药物涂层球囊 (DCB) 的 PREVISION 首次人体试验。该试验旨在评估SirolimusDCB 治疗周边动脉疾病患者的安全性和有效性，该疾病会显着影响患者的运动能力和生活品质。

药物涂层球囊领域的主要企业致力于技术进步，例如紫杉醇涂层球囊导管，以提高冠状动脉支架内血管再阻塞等治疗的有效性。这些进步旨在改善患者的治疗效果，并最大限度地降低与传统治疗方法相关的併发症风险。紫杉醇涂层球囊导管是一种专用装置，可在充气时将药物紫杉醇释放到动脉壁中，有助于防止血管再阻塞成形术后再狭窄。例如，2024 年 3 月，美国医疗设备製造商波士顿科学公司的 AGENT™ 药物涂层球囊 (DCB) 获得美国食品药物管理局(FDA) 的核准。该装置专门用于治疗冠状动脉疾病患者的冠状动脉支架内再血管再阻塞(ISR)，当先前植入支架的血管被斑块或疤痕组织阻塞或变窄时就会发生这种情况。

2022年11月，美国介入性心血管技术製造商Cordis以11亿美元收购了Med Alliance SA。 Cordis的目标是透过此次收购，到2027年为全球200万名患者提供其药物释放型球囊Celtion SLR™（缓释利莫司）。总部位于瑞士的Med Alliance SA是Sirolimus微囊药物涂层球囊的开发商。

药物涂层球囊市场的主要企业包括 Acotec Scientific AG、B.Braun Melsungen AG、Biosensors International Group Ltd、Medtronic Inc.、Boston Scientific Corporation、Opto Circuits、Concept Medical、Cardionovum GmbH、Endocor GmbH、Hexacath Sverige、iVasva Corporation、BIoTronik、Cook Medical、Cordis Corporation、Abbott Laboratories、Surmodics Inc.、Hexacath SAS、MicroPort、SurModics Inc. 和 Orchestra BioMed。

预计北美将成为2024年全球药物涂层球囊市场最大的地区，并有望成为预测期内成长最快的地区。药物涂层球囊市场报告涵盖以下地区：亚太地区、西欧、东欧、北美、南美、中东和非洲。

药物涂层球囊市场报告涵盖的国家：澳洲、巴西、中国、法国、德国、印度、印尼、日本、俄罗斯、韩国、英国、美国、加拿大、义大利、西班牙

药物涂层球囊市场包括Everolimus和佐他莫司药物涂层球囊的销售。该市场的价值是指“出厂价”，即商品製造商或生产商销售给其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接销售给最终客户的价值。该市场中的商品价值还包括商品製造商销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球药物涂层气球：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球药物涂层球囊市场：成长率分析
  • 全球药物涂层球囊市场表现：规模与成长，2019-2024
  • 全球药物涂层球囊市场预测：规模与成长，2024-2029年，2034年
  • 全球药物涂层球囊：总目标市场（TAM）

第六章 市场细分

  • 全球药物涂层球囊市场：依产品、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 周边动脉疾病
  • 冠状动脉疾病
  • 其他的
  • 全球药物涂层球囊市场（按药物类型、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 紫杉醇
  • Sirolimus
  • 全球药物涂层球囊市场（依最终用户、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 心导管实验室
  • 门诊手术中心
  • 全球药物涂层球囊市场：周边动脉疾病细分、类型、绩效及预测（2019-2024、2024-2029、2034）
  • 紫杉醇涂层球囊
  • Sirolimus涂层球囊
  • 全球药物涂层球囊市场：冠状动脉疾病细分市场、类型、绩效及预测（2019-2024、2024-2029、2034）
  • 紫杉醇涂层球囊
  • Sirolimus涂层球囊
  • Everolimus涂层球囊
  • 全球药物涂层球囊市场：其他细分市场、按类型、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 药物涂层球囊治疗股腘动脉病变
  • 用于治疗肾动脉病变的药物涂层球囊
  • 药物涂层球囊和其他血管应用

第七章 区域和国家分析

  • 全球药物涂层球囊市场：依地区、绩效及预测，2019-2024年、2024-2029年、2034年
  • 全球药物涂层球囊市场：依国家、绩效及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 药物涂层球囊市场：竞争格局
  • 药物涂层球囊市场：公司简介
    • Acotec Scientific AG
    • B. Braun Melsungen AG
    • Biosensors International Group Ltd
    • Medtronic Inc.
    • Boston Scientific Corporation

第31章：其他领先和创新企业

  • Opto Circuits
  • Concept Medical
  • Cardionovum GmbH
  • Endocor GmbH
  • Hexacath Sverige
  • iVascular SLU
  • Minvasys SAS
  • MedAlliance
  • QT Vascular Ltd
  • Terumo Corporation
  • BIoTronik
  • Cook Medical
  • Cordis Corporation
  • Abbott Laboratories
  • Surmodics Inc.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第35章：市场潜力大的国家与策略

  • 2029年药物涂装球囊市场：提供新机会的国家
  • 2029年药物涂装球囊市场：细分领域带来新机会
  • 2029年药物涂层球囊市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r24098u

A drug-coated balloon (DCB) is a medical device employed in the intervention of narrowed or obstructed blood vessels, particularly in interventional cardiology and interventional radiology. Its design facilitates the direct delivery of medication to the site of vascular disease while concurrently performing angioplasty.

The primary categories of products encompassed within drug-coated balloons include those tailored for peripheral artery disease, coronary artery disease, and other indications. Drug-coated balloons (DCBs) for peripheral artery disease are a specific type of medical device utilized in addressing peripheral artery disease (PAD). PAD is characterized by the narrowing or blockage of blood vessels outside the heart or in the lower extremities. Various drug types, such as paclitaxel and sirolimus, are employed, and the end-users encompass hospitals, cardiac catheterization labs, and ambulatory surgical centers.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The drug-coated balloons market research report is one of a series of new reports from The Business Research Company that provides drug-coated balloons market statistics, including drug-coated balloons industry global market size, regional shares, competitors with a drug-coated balloons market share, detailed drug-coated balloons market segments, market trends and opportunities, and any further data you may need to thrive in the drug-coated balloons industry. This drug-coated balloons market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The drug-coated balloons market size has grown rapidly in recent years. It will grow from $1.08 billion in 2024 to $1.24 billion in 2025 at a compound annual growth rate (CAGR) of 14.6%. The growth in the historic period can be attributed to increased cardiovascular disease burden, demand for minimally invasive procedures, prevalence of peripheral artery disease (pad), reducing restenosis rates, advancements in interventional cardiology.

The drug-coated balloons market size is expected to see rapid growth in the next few years. It will grow to $2.2 billion in 2029 at a compound annual growth rate (CAGR) of 15.5%. The growth in the forecast period can be attributed to increasing aging population, expansion of indications and applications, focus on outpatient and ambulatory care, integration with drug delivery innovations, global health initiatives. Major trends in the forecast period include regulatory approvals for new formulations, focus on minimizing side effects, emergence of bioresorbable coatings, market expansion in emerging economies, patient-centric approaches.

The forecast of 15.5% growth over the next five years indicates a slight reduction of 0.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on antiproliferative drug formulations and balloon surface modification technologies, sourced from key regions such as India and Mexico, which could lead to reduced endovascular treatment options and higher costs for arterial disease management.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of coronary artery disease (CAD) is projected to drive the growth of the drug-coated balloons market in the future. CAD is a medical condition characterized by the narrowing or blockage of the coronary arteries that supply blood to the heart muscle, often leading to heart attacks. Drug-coated balloons are medical devices used to treat coronary artery disease, releasing medication into the artery during the procedure to help prevent restenosis, which is the re-narrowing of the artery following angioplasty. For instance, a study published in the Journal of the American College of Cardiology in August 2022 indicated that all four cardiovascular risk factors are expected to rise among the general U.S. population from 2025 to 2060. Diabetes is projected to see the most significant increase at 39.3%, followed by dyslipidemia at 27.6%, hypertension at 25.1%, and obesity at 18.3%. Additionally, the researchers found that rates of heart failure (33.4%) and ischemic heart disease (30.7%) are expected to experience the largest increases, along with heart attacks (16.9%) and strokes (33.8%). Consequently, the rise in coronary artery disease prevalence is anticipated to boost the drug-coated balloon market.

The increasing number of ambulatory surgery centers is anticipated to propel the growth of the drug-coated balloon market. Ambulatory Surgical Centers (ASCs) are medical facilities dedicated to conducting surgical procedures that do not necessitate an overnight hospital stay. Drug-coated balloons play a crucial role in ASCs by offering shorter procedure times compared to standard balloons, resulting in improved patient throughput and reduced operational costs. For instance, VMG Health reported in September 2023 that the total number of Medicare-certified ambulatory surgery centers increased by 2.9% from 1752 in 2021 to 1804 in 2022. Hence, the growing prevalence of ambulatory surgery centers is a driving force behind the drug-coated balloon market's expansion.

Product innovations are emerging as a significant trend in the drug-coated balloon market. Leading companies in this sector are concentrating on developing new technological and innovative solutions to enhance their market position. For example, in August 2022, Becton, Dickinson, and Company (BD), a U.S.-based medical technology firm, initiated the PREVISION first-in-human trial for a peripheral sirolimus drug-coated balloon (DCB). This trial is designed to evaluate the safety and effectiveness of the sirolimus DCB for treating patients with peripheral artery disease, a condition that greatly affects mobility and quality of life.

Leading companies in the drug-coated balloon sector are dedicated to advancing their technologies, including paclitaxel-coated balloon catheters, to improve treatment efficacy for conditions such as coronary in-stent restenosis. These advancements aim to enhance patient outcomes and minimize the risk of complications associated with traditional therapies. Paclitaxel-coated balloon catheters are specialized devices that release the drug paclitaxel into the artery wall upon inflation, helping to prevent re-narrowing after angioplasty. For instance, in March 2024, Boston Scientific Corporation, a U.S.-based medical device manufacturer, received approval from the U.S. Food and Drug Administration (FDA) for its AGENT(TM) Drug-Coated Balloon (DCB). This device is designed specifically for treating coronary in-stent restenosis (ISR) in patients with coronary artery disease, which occurs when a previously stented blood vessel becomes obstructed or narrowed due to plaque or scar tissue.

In November 2022, Cordis, a US-based manufacturer of interventional cardiovascular technologies, completed the acquisition of Med Alliance SA for $1.1 billion. Through this acquisition, Cordis aims to globally provide the drug-eluting balloon SELUTION SLRTM (Sustained Limus Release) to two million patients by 2027. Med Alliance SA, based in Switzerland, is a developer of the sirolimus micro-reservoir drug-coated balloon.

Major companies operating in the drug-coated balloons market include Acotec Scientific AG, B. Braun Melsungen AG, Biosensors International Group Ltd, Medtronic Inc., Boston Scientific Corporation, Opto Circuits, Concept Medical, Cardionovum GmbH, Endocor GmbH, Hexacath Sverige, iVascular SLU, Minvasys SAS, MedAlliance, QT Vascular Ltd, Terumo Corporation, Biotronik, Cook Medical, Cordis Corporation, Abbott Laboratories, Surmodics Inc., Hexacath SAS, MicroPort, SurModics Inc., Orchestra BioMed

North America was the largest region in the global drug-coated balloons market in 2024, and is expected to be the fastest-growing region in the forecast period. The regions covered in the drug-coated balloons market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the drug-coated balloons market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The drug-coated balloons market consists of sales of everolimus and zotarolimus drug-coated balloons. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Drug-Coated Balloons Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on drug-coated balloons market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for drug-coated balloons ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The drug-coated balloons market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Drug-Coated Balloons For Peripheral Artery Disease; Drug-Coated Balloons For Coronary Artery Disease; Drug-Coated Balloons For Other Indications
  • 2) By Drug Type: Paclitaxel; Sirolimus
  • 3) By End User: Hospitals; Cardiac Catheterization Labs; Ambulatory Surgical Centers
  • Subsegments:
  • 1) By Drug-Coated Balloons For Peripheral Artery Disease: Paclitaxel-Coated Balloons; Sirolimus-Coated Balloons
  • 2) By Drug-Coated Balloons For Coronary Artery Disease: Paclitaxel-Coated Balloons; Sirolimus-Coated Balloons; Everolimus-Coated Balloons
  • 3) By Drug-Coated Balloons For Other Indications: Drug-Coated Balloons For Femoropopliteal Lesions; Drug-Coated Balloons For Renal Artery Lesions; Drug-Coated Balloons For Other Vascular Applications
  • Companies Mentioned: Acotec Scientific AG; B. Braun Melsungen AG; Biosensors International Group Ltd; Medtronic Inc.; Boston Scientific Corporation; Opto Circuits; Concept Medical; Cardionovum GmbH; Endocor GmbH; Hexacath Sverige; iVascular SLU; Minvasys SAS; MedAlliance; QT Vascular Ltd; Terumo Corporation; Biotronik; Cook Medical; Cordis Corporation; Abbott Laboratories; Surmodics Inc.; Hexacath SAS; MicroPort; SurModics Inc.; Orchestra BioMed
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Drug-Coated Balloons Market Characteristics

3. Drug-Coated Balloons Market Trends And Strategies

4. Drug-Coated Balloons Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Drug-Coated Balloons Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Drug-Coated Balloons PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Drug-Coated Balloons Market Growth Rate Analysis
  • 5.4. Global Drug-Coated Balloons Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Drug-Coated Balloons Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Drug-Coated Balloons Total Addressable Market (TAM)

6. Drug-Coated Balloons Market Segmentation

  • 6.1. Global Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Drug-Coated Balloons For Peripheral Artery Disease
  • Drug-Coated Balloons For Coronary Artery Disease
  • Drug-Coated Balloons For Other Indications
  • 6.2. Global Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Paclitaxel
  • Sirolimus
  • 6.3. Global Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Cardiac Catheterization Labs
  • Ambulatory Surgical Centers
  • 6.4. Global Drug-Coated Balloons Market, Sub-Segmentation Of Drug-Coated Balloons For Peripheral Artery Disease, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Paclitaxel-Coated Balloons
  • Sirolimus-Coated Balloons
  • 6.5. Global Drug-Coated Balloons Market, Sub-Segmentation Of Drug-Coated Balloons For Coronary Artery Disease, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Paclitaxel-Coated Balloons
  • Sirolimus-Coated Balloons
  • Everolimus-Coated Balloons
  • 6.6. Global Drug-Coated Balloons Market, Sub-Segmentation Of Drug-Coated Balloons For Other Indications, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Drug-Coated Balloons For Femoropopliteal Lesions
  • Drug-Coated Balloons For Renal Artery Lesions
  • Drug-Coated Balloons For Other Vascular Applications

7. Drug-Coated Balloons Market Regional And Country Analysis

  • 7.1. Global Drug-Coated Balloons Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Drug-Coated Balloons Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Drug-Coated Balloons Market

  • 8.1. Asia-Pacific Drug-Coated Balloons Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Drug-Coated Balloons Market

  • 9.1. China Drug-Coated Balloons Market Overview
  • 9.2. China Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Drug-Coated Balloons Market

  • 10.1. India Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Drug-Coated Balloons Market

  • 11.1. Japan Drug-Coated Balloons Market Overview
  • 11.2. Japan Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Drug-Coated Balloons Market

  • 12.1. Australia Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Drug-Coated Balloons Market

  • 13.1. Indonesia Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Drug-Coated Balloons Market

  • 14.1. South Korea Drug-Coated Balloons Market Overview
  • 14.2. South Korea Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Drug-Coated Balloons Market

  • 15.1. Western Europe Drug-Coated Balloons Market Overview
  • 15.2. Western Europe Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Drug-Coated Balloons Market

  • 16.1. UK Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Drug-Coated Balloons Market

  • 17.1. Germany Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Drug-Coated Balloons Market

  • 18.1. France Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Drug-Coated Balloons Market

  • 19.1. Italy Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Drug-Coated Balloons Market

  • 20.1. Spain Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Drug-Coated Balloons Market

  • 21.1. Eastern Europe Drug-Coated Balloons Market Overview
  • 21.2. Eastern Europe Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Drug-Coated Balloons Market

  • 22.1. Russia Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Drug-Coated Balloons Market

  • 23.1. North America Drug-Coated Balloons Market Overview
  • 23.2. North America Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Drug-Coated Balloons Market

  • 24.1. USA Drug-Coated Balloons Market Overview
  • 24.2. USA Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Drug-Coated Balloons Market

  • 25.1. Canada Drug-Coated Balloons Market Overview
  • 25.2. Canada Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Drug-Coated Balloons Market

  • 26.1. South America Drug-Coated Balloons Market Overview
  • 26.2. South America Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Drug-Coated Balloons Market

  • 27.1. Brazil Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Drug-Coated Balloons Market

  • 28.1. Middle East Drug-Coated Balloons Market Overview
  • 28.2. Middle East Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Drug-Coated Balloons Market

  • 29.1. Africa Drug-Coated Balloons Market Overview
  • 29.2. Africa Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Drug-Coated Balloons Market Competitive Landscape And Company Profiles

  • 30.1. Drug-Coated Balloons Market Competitive Landscape
  • 30.2. Drug-Coated Balloons Market Company Profiles
    • 30.2.1. Acotec Scientific AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. B. Braun Melsungen AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Biosensors International Group Ltd Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Medtronic Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Drug-Coated Balloons Market Other Major And Innovative Companies

  • 31.1. Opto Circuits
  • 31.2. Concept Medical
  • 31.3. Cardionovum GmbH
  • 31.4. Endocor GmbH
  • 31.5. Hexacath Sverige
  • 31.6. iVascular SLU
  • 31.7. Minvasys SAS
  • 31.8. MedAlliance
  • 31.9. QT Vascular Ltd
  • 31.10. Terumo Corporation
  • 31.11. Biotronik
  • 31.12. Cook Medical
  • 31.13. Cordis Corporation
  • 31.14. Abbott Laboratories
  • 31.15. Surmodics Inc.

32. Global Drug-Coated Balloons Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Drug-Coated Balloons Market

34. Recent Developments In The Drug-Coated Balloons Market

35. Drug-Coated Balloons Market High Potential Countries, Segments and Strategies

  • 35.1 Drug-Coated Balloons Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Drug-Coated Balloons Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Drug-Coated Balloons Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer